Sort   by:  
 Page size 
UnknownNeoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.
Not available
S-EPMC4304382 | biostudies-literature
UnknownA randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).
Not available
S-EPMC8558154 | biostudies-literature
Sort   by:  
 Page size